AT-58 JCOG0911 INTEGRA TRIAL: A RANDOMIZED SCREENING PHASE II TRIAL OF CHEMORADIOTHERAPY WITH INTERFERONβ PLUS TEMOZOLOMIDE VERSUS CHEMORADIOTHERAPY WITH TEMOZOLOMIDE ALONE FOR NEWLY-DIAGNOSED GLIOBLASTOMA

BACKGROUND: Our lab experiments showed that interferonβ (IFNβ) markedly enhanced chemosensitivity to temozolomide (TMZ) via the down-regulation of MGMT transcription. Followed by phase I trial, INTEGRA trial investigated the efficacy of TMZ + IFNβ therapy by a randomized screening design as compared...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Wakabayashi, Toshihiko, Natsume, Atsushi, Mizusawa, Junki, Katayama, Hiroshi, Fukuda, Haruhiko, Shibui, Soichiro, BTSG, Members JCOG
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2014
Onderwerpen:
Adult Clinical Trials
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217838/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.57
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items